Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-101671

Chief Strategy Officer sold 1,897 shares at $10.78 ($20,450)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nayak Sanjay Chief Strategy Officer 2026-08-24 Sale 10b5-1 −1,897 $10.78 $20,450 326,898 D
Open-market sales · 1,897 sh · avg $10.78 · $20,450
Loading xslF345X06/tm2624096-3_4seq1.xml…